HK1091118A1 - Functional influenza virus-like particles (vlps) - Google Patents
Functional influenza virus-like particles (vlps)Info
- Publication number
- HK1091118A1 HK1091118A1 HK06110664.8A HK06110664A HK1091118A1 HK 1091118 A1 HK1091118 A1 HK 1091118A1 HK 06110664 A HK06110664 A HK 06110664A HK 1091118 A1 HK1091118 A1 HK 1091118A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- influenza virus
- influenza
- particles
- vaccine
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/617,569 US8592197B2 (en) | 2003-07-11 | 2003-07-11 | Functional influenza virus-like particles (VLPs) |
PCT/US2004/022001 WO2005020889A2 (en) | 2003-07-11 | 2004-07-09 | Functional influenza virus-like particles (vlps) |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1091118A1 true HK1091118A1 (en) | 2007-01-12 |
Family
ID=33565000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06110664.8A HK1091118A1 (en) | 2003-07-11 | 2006-09-25 | Functional influenza virus-like particles (vlps) |
Country Status (20)
Country | Link |
---|---|
US (5) | US8592197B2 (de) |
EP (2) | EP2343084B1 (de) |
JP (5) | JP2007529997A (de) |
KR (1) | KR101153929B1 (de) |
CN (3) | CN103157103A (de) |
AT (1) | ATE538810T1 (de) |
AU (1) | AU2004268510B2 (de) |
BR (1) | BRPI0412519A (de) |
CA (1) | CA2532335C (de) |
DK (2) | DK1644037T3 (de) |
ES (2) | ES2422580T3 (de) |
HK (1) | HK1091118A1 (de) |
IL (1) | IL173071A (de) |
MX (1) | MXPA06000469A (de) |
NZ (1) | NZ544580A (de) |
PL (2) | PL1644037T3 (de) |
PT (2) | PT1644037E (de) |
RU (1) | RU2369405C2 (de) |
SG (2) | SG131116A1 (de) |
WO (1) | WO2005020889A2 (de) |
Families Citing this family (150)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2217967B1 (es) * | 2003-03-31 | 2006-01-01 | Consejo Sup. Investig. Cientificas | Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv. |
US8206950B2 (en) * | 2003-06-09 | 2012-06-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine and method of making them |
US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
US8080255B2 (en) | 2003-07-11 | 2011-12-20 | Novavax Inc. | Functional influenza virus like particles (VLPs) |
US8506967B2 (en) | 2003-07-11 | 2013-08-13 | Novavax, Inc. | Functional influenza virus like particles (VLPs) |
US8551756B2 (en) | 2003-07-11 | 2013-10-08 | Novavax, Inc. | Avian influenza chimeric VLPS |
US8992939B2 (en) | 2003-07-11 | 2015-03-31 | Novavax, Inc. | Highly efficient influenza matrix (M1) proteins |
US20160000902A1 (en) * | 2003-07-11 | 2016-01-07 | Novavax, Inc. | Combination vaccine for respiratory syncytial virus and influenza |
ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
ES2307345B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
GB0716992D0 (en) | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
US20090208517A1 (en) * | 2004-08-19 | 2009-08-20 | Bernhard Moser | Preparation Of Antigen-Presenting Human Gamma-Delta T Cells And Use In Immunotherapy |
AU2005274649B2 (en) * | 2004-08-19 | 2010-09-09 | University College Cardiff Consultants Limited | Preparation of antigen-presenting human gamma delta T cells and use in immunotherapy |
MX2007010008A (es) * | 2005-02-16 | 2008-01-18 | Lentigen Corp | Vectores lentivirales y su uso. |
WO2006116082A1 (en) | 2005-04-21 | 2006-11-02 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
ES2310062B1 (es) * | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
US8338173B2 (en) * | 2005-08-11 | 2012-12-25 | University College Cardiff Consultants Limited | Preparation of antigen-presenting human γδ T cells and use in immunotherapy |
TWI488968B (zh) * | 2005-10-18 | 2015-06-21 | Novavax Inc | 功能性流行性感冒類病毒顆粒(VLPs) |
NZ567809A (en) | 2005-10-19 | 2012-06-29 | Univ Florida | Influenza viruses able to infect canids, uses thereof |
WO2008048269A2 (en) * | 2005-10-20 | 2008-04-24 | Combimatrix Corporation | Microarray for pathogen identification |
GB2432419A (en) * | 2005-11-16 | 2007-05-23 | Agency Science Tech & Res | Influenza A virus detection method |
FI20051255A0 (fi) * | 2005-12-05 | 2005-12-05 | Pekka Untamo Heino | Seuraavaa influenssa A-pandemiaa vastaan soveltuva rokote |
US8232058B2 (en) * | 2006-01-20 | 2012-07-31 | Lawrence Livermore National Security, Llc | Multiplex detection of respiratory pathogens |
US7736642B2 (en) * | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
GB0613977D0 (en) | 2006-02-07 | 2006-08-23 | Peptcell Ltd | Peptide sequences and compositions |
US20070224205A1 (en) | 2006-03-07 | 2007-09-27 | Powell Thomas J | Compositions that include hemagglutinin, methods of making and methods of use thereof |
WO2007126788A2 (en) * | 2006-03-27 | 2007-11-08 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for the treatment and prevention of viral infection |
US20070243587A1 (en) * | 2006-04-14 | 2007-10-18 | Healthbanks Biotech Co., Ltd. | Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus |
WO2007130330A2 (en) * | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Polyvalent influenza virus-like particle (vlp) compositions |
US8778353B2 (en) | 2006-05-01 | 2014-07-15 | Technovax, Inc. | Influenza virus-like particle (VLP) compositions |
US20100143393A1 (en) * | 2006-05-11 | 2010-06-10 | Gale Smith | Novel influenza m2 vaccines |
KR100702034B1 (ko) * | 2006-05-12 | 2007-03-30 | 삼성전자주식회사 | 반도체 장치, 이 장치의 전원 노이즈 감소 방법 및 인쇄회로 기판 |
BRPI0714721A2 (pt) | 2006-07-14 | 2013-04-24 | Sanofi Pasteur Biologics Co | construÇço de vacinas de vÍrus recombinante por inserÇço direta mediada por transpàson de determinantes imunolàgicos estranhos em proteÍnas de vÍrus vetorial |
US9439959B2 (en) | 2006-07-27 | 2016-09-13 | Takeda Vaccines, Inc. | Chimeric influenza virus-like particles |
AU2007345682B2 (en) * | 2006-07-27 | 2013-07-18 | Ligocyte Pharmaceuticals, Inc. | Chimeric virus-like particles |
US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
US9598462B2 (en) | 2012-01-26 | 2017-03-21 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
US20100239605A1 (en) * | 2006-09-29 | 2010-09-23 | Sanofi Pasteur Biologics Co. | Recombinant Rhinovirus Vectors |
US7955603B2 (en) | 2006-09-29 | 2011-06-07 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
EP2069503B1 (de) * | 2006-11-15 | 2016-01-06 | Folia Biotech Inc. | Influenza-impfstoffe auf der basis von papmv |
US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
DK2540312T3 (en) * | 2007-07-19 | 2015-07-20 | Novavax Inc | Chimeric avian influenza VLPs |
US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
WO2009029686A1 (en) | 2007-08-27 | 2009-03-05 | Longhorn Vaccines & Diagnostics Llc | Immunogenic compositions and methods |
US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
AU2008343745B2 (en) | 2007-10-01 | 2012-05-10 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection and transport system and methods of use |
US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
ES2554703T3 (es) | 2007-11-27 | 2015-12-22 | Medicago Inc. | Partículas recombinantes semejantes al virus de la influenza (VLP) producidas en plantas transgénicas que expresan hemaglutinina |
EA034733B1 (ru) * | 2008-01-21 | 2020-03-13 | Медикаго Инк. | Нуклеиновая кислота для увеличенной экспрессии гемагглютинина вируса гриппа в растении и ее применение |
WO2009102229A1 (ru) * | 2008-02-15 | 2009-08-20 | A.N. Belozersky Institute Of Physico-Chemical Biology, Moscow State University | Липид-протеиновый рафтовый комплекс из оболочки вируса гриппа а для противогриппозных вакцин и способ его выделения, способ получения вирусоподобных частиц из таких комплексов |
RU2530555C2 (ru) | 2008-04-17 | 2014-10-10 | ПиДиЭс БАЙОТЕКНОЛОДЖИ КОРПОРЭЙШН | Стимуляция иммунного ответа энантиомерами катионных липидов |
SG190562A1 (en) * | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
CN102084252B (zh) | 2008-05-02 | 2017-03-22 | 罗切斯特大学 | 用于流感免疫应答测量的阵列检测器系统 |
US8450056B2 (en) | 2008-05-02 | 2013-05-28 | University Of Rochester | Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses |
CN101293099B (zh) * | 2008-06-04 | 2010-12-08 | 厦门大学 | 一种抗多种亚型禽流感病毒的多肽疫苗及其制备方法 |
ES2545607T3 (es) | 2008-07-08 | 2015-09-14 | Medicago Inc. | Antígenos de la gripe recombinantes solubles |
AU2009270404B2 (en) * | 2008-07-18 | 2015-01-29 | Medicago Inc. | New influenza virus immunizing epitope |
US20110206727A1 (en) * | 2008-07-30 | 2011-08-25 | Denis Leclerc | Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof |
IT1394782B1 (it) | 2009-03-03 | 2012-07-13 | Alenia Aeronautica Spa | Procedimento di predizione di collisioni tra un velivolo e un aeromobile |
US9051359B2 (en) * | 2009-03-30 | 2015-06-09 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccines and uses thereof |
NZ595710A (en) * | 2009-05-01 | 2013-10-25 | Redbiotec Ag | Recombinant virus-like particles encoded by multi-gene vector |
AU2010254136B2 (en) | 2009-05-26 | 2016-09-29 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
SG176820A1 (en) | 2009-06-24 | 2012-01-30 | Medicago Inc | Chimeric influenza virus-like particles comprising hemagglutinin |
WO2011003100A2 (en) | 2009-07-02 | 2011-01-06 | Massachusetts Institute Of Technology | Compositions and methods for diagnosing and/or treating influenza infection |
EP2480560B1 (de) | 2009-09-22 | 2018-02-21 | Medicago Inc. | Verfahren zur herstellung von aus pflanzen gewonnenen proteinen |
WO2011046925A1 (en) * | 2009-10-12 | 2011-04-21 | Technovax, Inc. | Respiratory syncytial virus (rsv) virus-like particles (vlps) |
EP2496609A4 (de) | 2009-11-03 | 2013-05-08 | Ligocyte Pharmaceuticals Inc | Chimäres rsv-f-polypeptid und vlps auf lentiviren- oder alpha-retroviren-gag-basis |
CA2789945A1 (en) * | 2010-02-18 | 2011-08-25 | Technovax, Inc. | Universal virus-like particle (vlp) influenza vaccines |
CA2790380A1 (en) | 2010-02-18 | 2011-08-25 | Mount Sinai School Of Medicine | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
US20110305748A1 (en) | 2010-03-11 | 2011-12-15 | Immune Design, Corp. | Vaccines for Pandemic Influenza |
EP3900740A1 (de) | 2010-03-30 | 2021-10-27 | Icahn School of Medicine at Mount Sinai | Influenzavirusimpfstoffe und verwendungen davon |
EP3578205A1 (de) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung |
CN102373184A (zh) * | 2010-08-09 | 2012-03-14 | 中山大学 | 禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用 |
CN102373182A (zh) * | 2010-08-09 | 2012-03-14 | 中山大学 | 禽流感和传染性囊病混合病毒样颗粒、制备方法和应用 |
AU2011305371B2 (en) | 2010-09-21 | 2015-05-21 | Massachusetts Institute Of Technology | Human-adapted HA polypeptides, vaccines, and influenza treatment |
CN104531812A (zh) | 2010-10-01 | 2015-04-22 | 现代治疗公司 | 设计核酸及其使用方法 |
BR112013007946B1 (pt) | 2010-10-04 | 2022-07-12 | Massachusetts Institute Of Technology | Composições farmacêuticas e imunogênicas compreendendo polipeptídeos de hemaglutinina |
HUE034247T2 (en) * | 2010-11-05 | 2018-02-28 | Novavax Inc | Rabies glycoprotein virus-like particles (VLP-K) |
TWI526539B (zh) * | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
CN103384531A (zh) * | 2010-12-22 | 2013-11-06 | 诺瓦瓦克斯股份有限公司 | 经修饰流感血凝素蛋白及其用途 |
TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
WO2012177760A1 (en) | 2011-06-20 | 2012-12-27 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for h1n1 influenza |
AU2012282658B2 (en) | 2011-07-11 | 2014-11-27 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
CN103945863A (zh) | 2011-08-01 | 2014-07-23 | 爱默蕾大学 | 包含配体的vlp及其相关方法 |
EP3275464A1 (de) | 2011-08-01 | 2018-01-31 | Emory University | Liganden-haltige vlps und entsprechende verfahren |
JP2014527799A (ja) | 2011-08-26 | 2014-10-23 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | 変異型pb2遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
EA201490659A1 (ru) | 2011-09-20 | 2014-11-28 | Маунт Синай Скул Оф Медсин | Вакцины против вируса гриппа и их применения |
ES2911677T3 (es) | 2011-10-03 | 2022-05-20 | Modernatx Inc | Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos |
RS63244B1 (sr) | 2011-12-16 | 2022-06-30 | Modernatx Inc | Kompozicije modifikovane mrna |
RU2018113521A (ru) | 2012-02-07 | 2019-03-04 | Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн | Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b |
US9566327B2 (en) | 2012-02-13 | 2017-02-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Computationally optimized broadly reactive antigens for human and avian H5N1 influenza |
RU2485973C1 (ru) * | 2012-02-28 | 2013-06-27 | Общество с ограниченной ответственностью "НТфарма" | Рекомбинантная трехвалентная вакцина от гриппа человека |
EP2827893B1 (de) | 2012-03-22 | 2017-11-29 | Fraunhofer USA, Inc. | Virusähnliche partikel, die ein matrixprotein eines umhüllten pflanzenvirus umfassen und deren verwendung |
RU2017141447A (ru) | 2012-03-30 | 2019-02-13 | Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн | Рекомбинантные полипептиды гемагглютинина (ha) вируса гриппа, композиции, содержащие их, и способы вызова иммунного ответа в отношении вируса гриппа h1n1 |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US20140010861A1 (en) | 2012-04-02 | 2014-01-09 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
WO2013177294A1 (en) * | 2012-05-22 | 2013-11-28 | Cornell University | Reagents and methods for identifying anti-hiv compounds |
US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
CN105101991A (zh) | 2012-09-21 | 2015-11-25 | Pds生物科技公司 | 改进的疫苗组合物和使用方法 |
KR101484588B1 (ko) | 2012-10-24 | 2015-01-20 | 대한민국 | 개 인플루엔자 vlp 백신의 제조방법 |
LT2922554T (lt) | 2012-11-26 | 2022-06-27 | Modernatx, Inc. | Terminaliai modifikuota rnr |
AU2013352179B2 (en) | 2012-11-27 | 2017-12-21 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for H1N1 influenza |
CN108641002A (zh) | 2012-12-18 | 2018-10-12 | 西奈山伊坎医学院 | 流感病毒疫苗及其用途 |
US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
PT3033102T (pt) | 2013-08-13 | 2019-12-19 | Univ Northwestern | Partículas conjugadas com péptidos |
CN103467581B (zh) * | 2013-08-26 | 2016-01-20 | 中国科学院微生物研究所 | 流感病毒m1蛋白及其编码基因和应用 |
WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
JP2016530294A (ja) | 2013-09-03 | 2016-09-29 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | キメラポリヌクレオチド |
US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
ES2864081T3 (es) | 2014-01-10 | 2021-10-13 | Medicago Inc | Elementos potenciadores de CPMV |
PT3134131T (pt) | 2014-04-23 | 2022-03-24 | Modernatx Inc | Vacinas de ácidos nucleicos |
US11273127B2 (en) | 2014-05-06 | 2022-03-15 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for thermally stable multi-targeted antigens |
WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
CA2955287A1 (en) * | 2014-07-18 | 2016-01-21 | The Chemo-Sero-Therapeutic Research Institute | Vaccine containing virus-like particles |
CA2974699A1 (en) | 2015-01-23 | 2016-07-28 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccination regimens |
KR101745472B1 (ko) | 2015-04-15 | 2017-06-12 | 대한민국 | 조류인플루엔자 바이러스의 세포 감염을 저해하는 물질을 선별하는 방법 |
CA2985652C (en) | 2015-05-14 | 2020-03-10 | Gerald W. FISHER | Rapid methods for the extraction of nucleic acids from biological samples |
WO2017040203A1 (en) * | 2015-08-28 | 2017-03-09 | Yoshihiro Kawaoka | Generation of infectious influenza viruses from virus-like particles |
EP3347044B1 (de) * | 2015-09-10 | 2023-04-19 | Academia Sinica | Vogelgrippeimpfstoffkombination mit virusähnlichen partikeln und neuartigen hilfsstoffen |
CA3005251A1 (en) | 2015-11-13 | 2017-05-18 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
US11266734B2 (en) | 2016-06-15 | 2022-03-08 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
CA3058652A1 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
EP3625246A1 (de) | 2017-05-18 | 2020-03-25 | ModernaTX, Inc. | Polynukleotide zur codierung von gebundenen interleukin-12 (il12)-polypeptiden und verwendungen davon |
CN107353328A (zh) * | 2017-08-23 | 2017-11-17 | 上海市动物疫病预防控制中心 | 一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途 |
CN107488216B (zh) * | 2017-09-06 | 2020-11-10 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种流感病毒通用疫苗及其制备方法与应用 |
CN110240634B (zh) * | 2018-03-08 | 2022-09-06 | 普莱柯生物工程股份有限公司 | 一种禽流感病毒样颗粒疫苗、及其制备方法和应用 |
CN110575538B (zh) * | 2018-06-11 | 2022-08-19 | 普莱柯生物工程股份有限公司 | 一种禽流感病毒样颗粒疫苗、及其制备方法和应用 |
CN109097341B (zh) * | 2018-08-28 | 2021-09-24 | 青岛农业大学 | 一种同时表达ha和hef的复制缺陷型重组流感病毒 |
EP3851120A4 (de) | 2018-09-11 | 2022-04-27 | Shanghai Public Health Clinical Center | Immunogen für influenza-impfstoff mit breitem spektrum und anwendung davon |
WO2020163804A1 (en) | 2019-02-08 | 2020-08-13 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
JP2022551805A (ja) | 2019-08-27 | 2022-12-14 | ウィスコンシン アルムニ リサーチ ファンデイション | 卵内複製のための安定化されたhaを持つ組換えインフルエンザウイルス |
CN113461786B (zh) * | 2020-03-30 | 2022-09-13 | 普莱柯生物工程股份有限公司 | 一种禽流感病毒样颗粒疫苗、及其制备方法和应用 |
CN113403343A (zh) * | 2021-04-30 | 2021-09-17 | 吉林大学 | 一种h3n2与h9n2亚型禽流感二价嵌合型病毒样颗粒的制备 |
CN113398259A (zh) * | 2021-04-30 | 2021-09-17 | 吉林大学 | 一种h9n2亚型禽流感新型标记疫苗的制备方法及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552758A (en) * | 1983-12-20 | 1985-11-12 | St. Jude Children's Research Hospital | Human use of avian-human reassortants as vaccines for influenza A virus |
US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
ATE280585T1 (de) | 1994-02-24 | 2004-11-15 | Micro Pak Inc | Impfstoffe, die paucilamelläre lipidvesikel als adjuvans enthalten |
AU3760495A (en) | 1994-09-30 | 1996-04-26 | Aviron | Chimeric Influenza Virus And Electroporation Method |
TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
US5945489A (en) | 1997-09-19 | 1999-08-31 | Ashland, Inc. | Liquid oligomers containing unsaturation |
US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
US6544785B1 (en) * | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
US8715940B2 (en) * | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
BRPI0111830B8 (pt) * | 2000-06-23 | 2021-05-25 | American Cyanamid Co | método de produção de partículas semelhantes ao vírus da influenza (vlps), vlps da influenza, vlps quiméricas, composições imunogênica e farmacêutica, e, usos de vlps da influenza e de vlps quiméricas |
US6513184B1 (en) | 2000-06-28 | 2003-02-04 | S. C. Johnson & Son, Inc. | Particle entrapment system |
KR100979025B1 (ko) * | 2001-12-07 | 2010-08-30 | 크루셀 홀란드 비.브이. | 바이러스, 바이러스 단리물 및 백신의 생산 |
AU2002359792A1 (en) | 2001-12-18 | 2003-06-30 | Proteologics, Inc. | Methods and compositions for the inhibition of viral release |
US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
US8506967B2 (en) | 2003-07-11 | 2013-08-13 | Novavax, Inc. | Functional influenza virus like particles (VLPs) |
US8080255B2 (en) * | 2003-07-11 | 2011-12-20 | Novavax Inc. | Functional influenza virus like particles (VLPs) |
US8551756B2 (en) | 2003-07-11 | 2013-10-08 | Novavax, Inc. | Avian influenza chimeric VLPS |
US8992939B2 (en) * | 2003-07-11 | 2015-03-31 | Novavax, Inc. | Highly efficient influenza matrix (M1) proteins |
-
2003
- 2003-07-11 US US10/617,569 patent/US8592197B2/en active Active
-
2004
- 2004-07-09 EP EP10010286.2A patent/EP2343084B1/de not_active Expired - Lifetime
- 2004-07-09 RU RU2006104113/13A patent/RU2369405C2/ru active
- 2004-07-09 JP JP2006518925A patent/JP2007529997A/ja not_active Withdrawn
- 2004-07-09 ES ES10010286T patent/ES2422580T3/es not_active Expired - Lifetime
- 2004-07-09 SG SG200701731-2A patent/SG131116A1/en unknown
- 2004-07-09 ES ES04786052T patent/ES2380021T3/es not_active Expired - Lifetime
- 2004-07-09 MX MXPA06000469A patent/MXPA06000469A/es active IP Right Grant
- 2004-07-09 PL PL04786052T patent/PL1644037T3/pl unknown
- 2004-07-09 PT PT04786052T patent/PT1644037E/pt unknown
- 2004-07-09 DK DK04786052.3T patent/DK1644037T3/da active
- 2004-07-09 AU AU2004268510A patent/AU2004268510B2/en active Active
- 2004-07-09 CN CN2013100841712A patent/CN103157103A/zh active Pending
- 2004-07-09 CA CA2532335A patent/CA2532335C/en not_active Expired - Lifetime
- 2004-07-09 CN CN201710658288.5A patent/CN107513102A/zh active Pending
- 2004-07-09 DK DK10010286.2T patent/DK2343084T3/da active
- 2004-07-09 PT PT100102862T patent/PT2343084E/pt unknown
- 2004-07-09 SG SG201006667-8A patent/SG165378A1/en unknown
- 2004-07-09 KR KR1020067000719A patent/KR101153929B1/ko active IP Right Grant
- 2004-07-09 NZ NZ544580A patent/NZ544580A/en unknown
- 2004-07-09 AT AT04786052T patent/ATE538810T1/de active
- 2004-07-09 BR BRPI0412519-3A patent/BRPI0412519A/pt not_active Application Discontinuation
- 2004-07-09 WO PCT/US2004/022001 patent/WO2005020889A2/en active Application Filing
- 2004-07-09 EP EP04786052A patent/EP1644037B1/de not_active Expired - Lifetime
- 2004-07-09 CN CNA2004800261523A patent/CN1849134A/zh active Pending
- 2004-07-09 PL PL10010286T patent/PL2343084T3/pl unknown
-
2006
- 2006-01-10 IL IL173071A patent/IL173071A/en active IP Right Grant
- 2006-03-10 US US11/372,466 patent/US7763450B2/en active Active
- 2006-09-25 HK HK06110664.8A patent/HK1091118A1/xx unknown
-
2010
- 2010-09-16 JP JP2010208644A patent/JP2011046715A/ja active Pending
-
2013
- 2013-03-12 US US13/796,125 patent/US9144607B2/en not_active Expired - Lifetime
- 2013-07-05 JP JP2013141285A patent/JP2013216685A/ja not_active Withdrawn
-
2014
- 2014-12-22 JP JP2014258346A patent/JP2015057447A/ja not_active Withdrawn
-
2015
- 2015-04-30 US US14/700,577 patent/US9474799B2/en not_active Expired - Lifetime
-
2016
- 2016-06-02 JP JP2016110634A patent/JP2016164195A/ja active Pending
- 2016-10-24 US US15/332,330 patent/US9956280B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173071A0 (en) | Functional influenza virus-like particles (vlps) | |
Jeong et al. | Exploiting virus-like particles as innovative vaccines against emerging viral infections | |
BRPI0922867B8 (pt) | glicoproteina de fusão (f) de vírus sincicial respiratório (rsv), ácido nucleico isolado, célula hospedeira, composição de vacina e micela purificada | |
ES2459166T3 (es) | Procedimiento para la producción de vacunas víricas | |
CY1113875T1 (el) | Βελτιστοποιημενη εκφραση hpv 58 l1 σε ζυμομυκητα | |
TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
AP1872A (en) | Virus-like particles of human papillomavirus. | |
EP2708549A3 (de) | Verbesserte Impfstoffe und Verfahren zu ihrer Verwendung | |
RU2008119501A (ru) | Функциональные вирусоподоюные частицы гриппа (vlps) | |
FR15C0079I2 (fr) | Expression optimisee de hpv 31 l1 dans la levure | |
BRPI0707300A8 (pt) | Vacina contra vírion influenza dividido ou antígeno de superfície purificado e método para a preparação de uma composição imunogênica | |
ATE552846T1 (de) | Verbesserter grippeimpfstoff | |
MY140664A (en) | Optimized expression of hpv 45 l1 in yeast | |
WO2008092854A3 (en) | Papillomavirus e2 polypeptide used for vaccination | |
BR0312474A (pt) | Partìcula viral adjuvante | |
JP2015504897A5 (de) | ||
Pushko et al. | Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus | |
JP2010506926A5 (de) | ||
MY144492A (en) | Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types | |
ATE508185T1 (de) | Virosomenpartikel mit antigenen aus influenzavirus und hepatitis-b-virus | |
WO2007008093A3 (en) | A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine | |
Cobbin et al. | Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza | |
AR041515A1 (es) | Vacuna a dna contra el virus de papiloma humano | |
WO2007039458A3 (en) | Hiv peptide conjugates and uses thereof | |
Gencoglu | Purification and effectiveness of vaccines and antiviral compounds |